By Laura Kemp • Published: 05 Apr 2020 • 11:01
THE scientists who hail from TC Biopharm, a centre near Glasgow, have previously used this immunity-building cell infusion therapy with treated cancer patients, and they now hope that this same method will be able to fight the coronavirus.
A senior strategic medical advisor, Dr Brian Kelly, instructed that “One of the key challenges of fighting viral infection is to develop something that is going to attack the infected cells and not the normal cells.
“In patients who have successfully fought a viral infection, they have expanded their own immune system and which persists after that to stop them becoming infected again,” he followed.
Discussions with the UK government have begun, and the firm hopes to have the therapy up and running in NHS hospitals by July.
The effective aspect about this therapy is that even if the virus were to mutate, the infusion exercise could be repeated and still function as it had previously.
Share this story
Subscribe to our Euro Weekly News alerts to get the latest stories into your inbox!
By signing up, you will create a Euro Weekly News account if you don't already have one. Review our Privacy Policy for more information about our privacy practices.
Originally from UK, Laura is based in Axarquia and is a writer for the Euro Weekly News covering news and features. Got a news story you want to share? Then get in touch at editorial@euroweeklynews.com.
By signing up, you will create a Euro Weekly News account if you don’t already have one. Review our Privacy Policy for more information about our privacy practices.
Download our media pack in either English or Spanish.